By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioCon Limited 

20th KM Hosur Road

Electronics City  Bangalore  560 100  India
Phone: 90-80-2808-2808 Fax: 91-80-2852-3423


SEARCH JOBS


Industry
Biotechnology






Company News
Mylan (MYL) Release: FDA Accepts Biologics License Application (BLA) For Pharma And BioCon (BIOCON.NS)'s Proposed Biosimilar Trastuzumab 1/11/2017 6:24:25 AM
JAMA Publishes Mylan (MYL) And BioCon (BIOCON.NS)'s Proposed Biosimilar Trastuzumab Phase 3 Data 12/27/2016 10:57:33 AM
Mylan (MYL) And BioCon (BIOCON.NS) Announce U.S. FDA Submission For Proposed Biosimilar Trastuzumab 11/9/2016 11:40:15 AM
Mylan (MYL) And BioCon (BIOCON.NS) Announce Regulatory Submission For Insulin Glargine Accepted For Review By EMA 11/3/2016 7:37:39 AM
Mylan (MYL) And BioCon (BIOCON.NS) Announce Regulatory Submission For Proposed Biosimilar Trastuzumab Accepted For Review By EMA 8/25/2016 9:39:50 AM
Mylan (MYL) And BioCon (BIOCON.NS) Announce Regulatory Submission For Proposed Biosimilar Pegfilgrastim Accepted For Review By European Medicines Agency 7/21/2016 9:50:41 AM
BioCon (BIOCON.NS), Quark Pharmaceuticals Inc. Announce Initiation Of Pivotal Phase II/III Study Of QPI-1007 In Rare Eye Disease In India 6/23/2016 6:09:02 AM
ASCO2016: Mylan (MYL)-BioCon (BIOCON.NS)'s Biosimilar Cancer Drug Comparable to Roche (RHHBY)'s Herceptin 6/6/2016 7:38:00 AM
BioCon Limited (BIOCON.NS) Gears Up For US Generics Push 8/7/2015 7:28:01 AM
Industry Titans BioCon Limited (BIOCON.NS), PBOA, Biotec Services And Pharmatech Associates Join CPhI Annual Report For 2015 7/16/2015 2:50:03 PM
12345
//-->